Clinical Research Directory
Browse clinical research sites, groups, and studies.
Response Surface Modeling of Remimazolam and Sevoflurane
Sponsor: Pusan National University Yangsan Hospital
Summary
This prospective randomized open-label study aims to investigate the pharmacodynamic interaction between remimazolam and sevoflurane during general anesthesia using response surface modeling. Although remimazolam has favorable hemodynamic stability compared with propofol, its hypnotic effect may be less predictable and poorly correlated with conventional sedation monitoring indices such as the bispectral index (BIS). In clinical practice, remimazolam and sevoflurane are often combined during induction and maintenance of anesthesia; however, the optimal interaction between these agents remains unclear. This study will evaluate whether the interaction between remimazolam and sevoflurane is synergistic, additive, or infra-additive using two representative response surface interaction models: the Minto model and the Greco model. BIS values and predicted effect-site concentrations will be analyzed using NONMEM software.
Official title: Response Surface Model Between Remimazolam and Sevoflurane; Comparison of the Minto and the Greco Model
Key Details
Gender
All
Age Range
20 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
80
Start Date
2026-05-15
Completion Date
2027-12-31
Last Updated
2026-06-02
Healthy Volunteers
No
Conditions
Interventions
Remimazolam (Byfavo)
Remimazolam will be administered at infusion rates ranging from 0 to 6 mg/kg/h using an infusion pump with pharmacokinetic simulation software.
Sevoflurane (Volatile Anesthetic)
Sevoflurane will be administered by inhalation with targeted end-tidal concentrations between 0 and 2 vol%.
Locations (1)
Pusan National University Yangsan Hospital
Yangsan, South Korea